4.86
-0.12(-2.41%)
Currency In USD
| Previous Close | 4.98 |
| Open | 4.92 |
| Day High | 5.02 |
| Day Low | 4.76 |
| 52-Week High | 13.79 |
| 52-Week Low | 4.05 |
| Volume | 8,762 |
| Average Volume | 35,087 |
| Market Cap | 63.82M |
| PE | -0.86 |
| EPS | -5.66 |
| Moving Average 50 Days | 5.01 |
| Moving Average 200 Days | 5.92 |
| Change | -0.12 |
If you invested $1000 in INNOVATE Corp. (VATE) 10 years ago, it would be worth $0 as of December 04, 2025 at a share price of $4.86. Whereas If you bought $1000 worth of INNOVATE Corp. (VATE) shares 5 years ago, it would be worth $140.46 as of December 04, 2025 at a share price of $4.86.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
INNOVATE Corp. to Report Third Quarter 2025 Results on November 12th
GlobeNewswire Inc.
Oct 22, 2025 8:05 PM GMT
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the third quarter 2025 on Wednesday, November 12, 2025, after market close. The Com
MediBeacon receives regulatory approval to sell the Transdermal GFR System in China
GlobeNewswire Inc.
Oct 21, 2025 12:05 PM GMT
MediBeacon® Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal functionThe TGFR will be available for sale in China before the end of the year NEW YORK, O
INNOVATE’s Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial® Skin Continuing to Redefine Aesthetic Innovation
GlobeNewswire Inc.
Sep 09, 2025 12:39 PM GMT
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced that R2 Technologies, Inc. (“R2”), the innovators behind the breakthrough Glacial® Skin technology, and an operating subsidiary o